Accepted at 4:57 p.m. Jan, 27, 2024 by herstein.jacob
Author: tedmd2023
Related Note: 1463845182983 1
Rationale for change

Hypernatremia is a disorder of sodium concentration. "Levels" is too ambiguous and somewhat implies that more sodium is somehow being reabsorbed, but the change is only in volume (water).

Source: Other - Change "levels" to concentration

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs::*SIADH_Treatment #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::13_ADH-Related_Drugs #AK_Step2_v12::#B&B::15_Renal_and_Genitourinary::05_Other::06_Cystic_Kidney_Disease #AK_Step1_v12::#UWorld::Step::18948 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::04_Hypothalamic_&_Pituitary::02_ADH,_DDAVP,_ADH_receptor_antagonists #AK_Step1_v12::#Pixorize::03_Pharmacology::09_Other_Endocrine_Pharm::02_ADH_Antagonists_(Conivaptan/Tolvaptan) #AK_Step1_v12::#OME::PreClinical::Renal #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs::*Vaptans #AK_Step2_v12::#B&B::15_Renal_and_Genitourinary::02_Fluids_and_Electrolytes::02_Hyponatremia::Extra #AK_Step1_v12::#UWorld::COMLEX::26868 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield